JP6810991B2 - 離散時間状態空間動的モデルに基づく状態推定器と組み合わされたコントローラを使用する薬物送達システムの作動方法、該コントローラおよび該システム - Google Patents

離散時間状態空間動的モデルに基づく状態推定器と組み合わされたコントローラを使用する薬物送達システムの作動方法、該コントローラおよび該システム Download PDF

Info

Publication number
JP6810991B2
JP6810991B2 JP2017506924A JP2017506924A JP6810991B2 JP 6810991 B2 JP6810991 B2 JP 6810991B2 JP 2017506924 A JP2017506924 A JP 2017506924A JP 2017506924 A JP2017506924 A JP 2017506924A JP 6810991 B2 JP6810991 B2 JP 6810991B2
Authority
JP
Japan
Prior art keywords
state
time
controller
sensor
discrete
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017506924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523852A (ja
JP2017523852A5 (enExample
Inventor
ドイル，フランシス・ジェイ・ザ・サード
ゴンダレカール，ラビ・エル
ダッソウ，イーヤル
Original Assignee
リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア, リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア filed Critical リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
Publication of JP2017523852A publication Critical patent/JP2017523852A/ja
Publication of JP2017523852A5 publication Critical patent/JP2017523852A5/ja
Application granted granted Critical
Publication of JP6810991B2 publication Critical patent/JP6810991B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic using feedback of body parameters, e.g. blood sugar or pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/18—General characteristics of the apparatus with alarm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Feedback Control In General (AREA)
JP2017506924A 2014-08-06 2015-08-05 離散時間状態空間動的モデルに基づく状態推定器と組み合わされたコントローラを使用する薬物送達システムの作動方法、該コントローラおよび該システム Active JP6810991B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462034132P 2014-08-06 2014-08-06
US62/034,132 2014-08-06
PCT/US2015/043763 WO2016022650A1 (en) 2014-08-06 2015-08-05 Moving-horizon state-initializer for control applications

Publications (3)

Publication Number Publication Date
JP2017523852A JP2017523852A (ja) 2017-08-24
JP2017523852A5 JP2017523852A5 (enExample) 2018-08-23
JP6810991B2 true JP6810991B2 (ja) 2021-01-13

Family

ID=55264479

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506924A Active JP6810991B2 (ja) 2014-08-06 2015-08-05 離散時間状態空間動的モデルに基づく状態推定器と組み合わされたコントローラを使用する薬物送達システムの作動方法、該コントローラおよび該システム

Country Status (7)

Country Link
US (2) US9984773B2 (enExample)
EP (1) EP3177344B1 (enExample)
JP (1) JP6810991B2 (enExample)
CN (1) CN106714874B (enExample)
AU (1) AU2015301146B2 (enExample)
CA (1) CA2957432C (enExample)
WO (1) WO2016022650A1 (enExample)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7972296B2 (en) 2007-10-10 2011-07-05 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8417311B2 (en) 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
WO2014172467A1 (en) 2013-04-16 2014-10-23 Smartloop Llc Discretionary insulin delivery systems and methods
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
DE102015000845A1 (de) * 2015-01-27 2016-07-28 W.O.M. World Of Medicine Gmbh Verfahren und Vorrichtung zur Regelung der Temperatur des Gasstroms bei medizintechnischen Vorrichtungen
CA2977053C (en) 2015-02-18 2023-08-01 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
EP3374905A1 (en) 2016-01-13 2018-09-19 Bigfoot Biomedical, Inc. User interface for diabetes management system
EP4545005A3 (en) 2016-01-14 2025-07-02 Insulet Corporation Adjusting insulin delivery rates
HK1256995A1 (zh) 2016-01-14 2019-10-11 Bigfoot Biomedical, Inc. 药物输送设备、系统和方法中的阻塞解决方案
US12383166B2 (en) 2016-05-23 2025-08-12 Insulet Corporation Insulin delivery system and methods with risk-based set points
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
AU2017376111B2 (en) 2016-12-12 2023-02-02 Bigfoot Biomedical, Inc. Alarms and alerts for medication delivery devices and related systems and methods
EP4708310A3 (en) 2017-01-13 2026-05-06 Insulet Corporation Insulin delivery methods, systems and devices
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10881793B2 (en) 2017-01-13 2021-01-05 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
EP4708311A3 (en) 2017-01-13 2026-05-20 Insulet Corporation METHODS, SYSTEMS AND DEVICES FOR INSULIN ADMINISTRATION
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
CA3059985C (en) 2017-05-05 2023-08-08 Eli Lilly And Company Closed loop control of physiological glucose
US12653426B2 (en) 2017-07-13 2026-06-16 Bigfoot Biomedical, Inc. Multi-scale display of blood glucose information
EP4765154A2 (en) 2017-08-02 2026-06-24 Diabeloop Closed-loop blood glucose control systems and methods
JP7133625B2 (ja) 2017-12-21 2022-09-08 イーライ リリー アンド カンパニー 生理的グルコースの閉ループ制御
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11565043B2 (en) 2018-05-04 2023-01-31 Insulet Corporation Safety constraints for a control algorithm based drug delivery system
US12562251B1 (en) 2018-05-09 2026-02-24 Bigfoot Biomedical, Inc. Computing architecture for assuring the provenance of medication therapy related parameters, and related systems, methods and devices
CN112313754A (zh) 2018-06-22 2021-02-02 伊莱利利公司 胰岛素和普兰林肽输送系统、方法和设备
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4354455B1 (en) 2019-12-06 2025-10-29 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
WO2021141941A1 (en) 2020-01-06 2021-07-15 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
WO2021158580A1 (en) 2020-02-03 2021-08-12 Insulet Corporation Use of fuzzy logic in predicting user behavior affecting blood glucose concentration
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US12495994B2 (en) 2020-02-20 2025-12-16 Insulet Corporation Meal bolus subcategories in model based insulin therapy
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11132352B1 (en) 2020-05-13 2021-09-28 International Business Machines Corporation Utilizing local IoT devices to reconcile data mismatches
JP7723008B2 (ja) 2020-05-27 2025-08-13 デックスコム・インコーポレーテッド 機械学習及び時系列グルコース測定値を使用したグルコース予測
US12121700B2 (en) 2020-07-22 2024-10-22 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US12569619B2 (en) 2020-09-21 2026-03-10 Insulet Corporation Techniques for determining automated insulin delivery dosages
EP4696344A3 (en) 2020-09-30 2026-04-15 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
US12115351B2 (en) 2020-09-30 2024-10-15 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
CA3191704A1 (en) 2021-01-25 2022-07-28 Dexcom, Inc. Bayesian framework for personalized model identification and prediction of future blood glucose in type 1 diabetes using easily accessible patient data
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
EP4285376A1 (en) 2021-01-29 2023-12-06 Insulet Corporation Techniques and devices that adapt basal profiles for drug delivery applications
US12636435B2 (en) 2021-02-26 2026-05-26 Insulet Corporation Techniques for optimizing usage of an automatic drug delivery system
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
WO2022192482A1 (en) 2021-03-10 2022-09-15 Insulet Corporation A medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions
CN113223721B (zh) * 2021-03-23 2022-07-12 杭州电子科技大学 一种新型冠状病毒肺炎的预测控制模型
US12592306B2 (en) 2021-04-28 2026-03-31 Insulet Corporation Devices and methods for initialization of drug delivery devices using measured analyte sensor information
US12496398B2 (en) 2021-05-28 2025-12-16 Insulet Corporation Threshold based automatic glucose control response
EP4101482A1 (en) 2021-06-07 2022-12-14 Insulet Corporation Exercise safety prediction based on physiological conditions
US12514980B2 (en) 2021-06-30 2026-01-06 Insulet Corporation Adjustment of medicament delivery by a medicament delivery device based on menstrual cycle phase
US12521486B2 (en) 2021-07-16 2026-01-13 Insulet Corporation Method for modification of insulin delivery during pregnancy in automatic insulin delivery systems
US12653949B2 (en) 2021-07-29 2026-06-16 Insulet Corporation Adaptation of medicament delivery in response to user stress load
EP4409581A1 (en) 2021-09-27 2024-08-07 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
WO2023150737A1 (en) 2022-02-07 2023-08-10 Insulet Corporation Techniques for determining medication correction factors in automatic medication delivery systems
US12653459B2 (en) 2022-02-23 2026-06-16 Massachusetts Institute Of Technology Systems, devices, and methods for blood pressure control
EP4243030A1 (en) 2022-03-09 2023-09-13 Insulet Corporation Adjusting medicament delivery parameters in an open loop medicament delivery mode
EP4511843A1 (en) 2022-04-21 2025-02-26 Insulet Corporation Insulin adaptation and safety monitoring for sick day management
KR20250129777A (ko) 2023-01-06 2025-08-29 인슐렛 코포레이션 후속 자동 안전 제약 완화를 갖는 자동으로 또는 수동으로 개시되는 음식 볼러스 전달
CN117170238B (zh) * 2023-09-15 2024-04-16 四川大学 基于协作分布式mpc的异构无人机集群搜索算法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080119703A1 (en) * 2006-10-04 2008-05-22 Mark Brister Analyte sensor
US8364231B2 (en) * 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
US20080269714A1 (en) * 2007-04-25 2008-10-30 Medtronic Minimed, Inc. Closed loop/semi-closed loop therapy modification system
US7717903B2 (en) * 2007-09-06 2010-05-18 M2 Group Holdings, Inc. Operating an infusion pump system
US7695434B2 (en) * 2007-10-19 2010-04-13 Lifescan Scotland, Ltd. Medical device for predicting a user's future glycemic state
WO2009059187A1 (en) * 2007-11-02 2009-05-07 University Of Virginia Patent Foundation Predictive control based system and method for control of insulin delivery in diabetes using glucose sensing
US8185217B2 (en) * 2008-01-31 2012-05-22 Fisher-Rosemount Systems, Inc. Robust adaptive model predictive controller with tuning to compensate for model mismatch
US20100057040A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US8734422B2 (en) * 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
EP2413781B1 (en) * 2009-03-31 2019-07-24 Abbott Diabetes Care Inc. Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model
US8597274B2 (en) * 2009-05-22 2013-12-03 Abbott Diabetes Care Inc. Usability features for integrated insulin delivery system
WO2010135638A2 (en) * 2009-05-22 2010-11-25 Abbott Diabetes Care Inc. Methods for reducing false hypoglycemia alarm occurrence
EP2433235A2 (en) * 2009-05-22 2012-03-28 Abbott Diabetes Care, Inc. Safety features for integrated insulin delivery system
WO2011014851A1 (en) * 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
WO2011051922A2 (en) * 2009-11-02 2011-05-05 Università Degli Studi Di Padova Method to recalibrate continuous glucose monitoring data on-line
US20110313680A1 (en) * 2010-06-22 2011-12-22 Doyle Iii Francis J Health Monitoring System
EP2628115B1 (en) * 2010-10-12 2015-06-03 The Regents of The University of California Insulin delivery device
CA2841086C (en) * 2011-09-28 2021-01-26 Abbott Diabetes Care Inc. Methods, devices and systems for analyte monitoring management
WO2013104006A2 (en) * 2012-01-08 2013-07-11 Sensor Platforms, Inc. System and method for calibrating sensors for different operating environments
US9907909B2 (en) * 2012-12-20 2018-03-06 Animas Corporation Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas
EP2943150B1 (en) * 2013-01-14 2018-12-05 The Regents of The University of California Daily periodic target-zone modulation in the model predictive control problem for artificial pancreas for type i diabetes applications
US9486171B2 (en) * 2013-03-15 2016-11-08 Tandem Diabetes Care, Inc. Predictive calibration
CN103605878B (zh) * 2013-08-19 2016-03-30 浙江大学 一种基于数据建模和模型移植的通用血糖预测方法
CN103793594A (zh) * 2013-12-30 2014-05-14 上海交通大学医学院附属瑞金医院 一种构建肠道-胰岛调控轴相关功能评估模型的方法与应用
US10314547B2 (en) * 2014-04-09 2019-06-11 Halo Wearables LLC Calibration of a wearable medical device
US9949673B2 (en) * 2014-08-26 2018-04-24 MAXIM lNTEGRATED PRODUCTS, INC. System, method and apparatus with multiple reservoirs for in situ calibration of implantable sensors

Also Published As

Publication number Publication date
WO2016022650A1 (en) 2016-02-11
JP2017523852A (ja) 2017-08-24
US20180277253A1 (en) 2018-09-27
CA2957432A1 (en) 2016-02-11
EP3177344A1 (en) 2017-06-14
AU2015301146A1 (en) 2017-03-16
US9984773B2 (en) 2018-05-29
CN106714874B (zh) 2019-10-08
AU2015301146B2 (en) 2020-06-25
CN106714874A (zh) 2017-05-24
US11189381B2 (en) 2021-11-30
EP3177344A4 (en) 2017-08-09
EP3177344B1 (en) 2023-06-28
US20170147781A1 (en) 2017-05-25
CA2957432C (en) 2017-07-25

Similar Documents

Publication Publication Date Title
CN106714874B (zh) 用于控制应用的滚动时域状态初始化器
EP2166946B1 (en) Lqg artificial pancreas control system and related method
Messori et al. Model individualization for artificial pancreas
Parker et al. A model-based algorithm for blood glucose control in type I diabetic patients
EP2223251B1 (en) Method and apparatus for monitoring a substance in human or animal bodies
EP3277180B1 (en) System for analyzing glucose data measured from a person having diabetes
Magni et al. Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial
KR102398749B1 (ko) 환자의 혈당 조절용 자동 시스템
JP2019055258A (ja) Ｉ型糖尿病用の人工膵臓のモデルベース個別化スキーム
JP7290624B2 (ja) 閉ループ血糖制御システム及び閉ループ血糖制御システムの作動方法
KR102398748B1 (ko) 환자의 혈당 조절용 자동 시스템
WO2011051922A2 (en) Method to recalibrate continuous glucose monitoring data on-line
WO2002024065A1 (en) Method and apparatus for real-time estimation and control of pysiological parameters
EP2475356B1 (en) Devices, systems and methods for adjusting fluid delivery parameters
Eberle et al. Real-time state estimation and long-term model adaptation: a two-sided approach toward personalized diagnosis of glucose and insulin levels
MohammadRidha et al. A variable reference trajectory for model-free glycemia regulation
JP7424996B2 (ja) 患者の血糖値をモニタするための自動システム
JP2019536588A (ja) 人工膵臓
Boiroux et al. Assessment of model predictive and adaptive glucose control strategies for people with type 1 diabetes
Boiroux et al. Nonlinear model predictive control for an artificial β-cell
Gondhalekar et al. State Estimation with Sensor Recalibrations and Asynchronous Measurements for MPC of an Artificial Pancreas to Treat T1DM
WO2019025507A1 (en) SYSTEMS AND METHODS FOR CONTROLLING CLOSED LOOP GLYCEMIA RATES
Rubb et al. Glucose control in type I diabetic patients: A Volterra model-based approach
EP4651145A1 (en) Closed-loop blood glucose control systems and methods
Orozco López et al. Linear time-varying Luenberger observer applied to diabetes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180710

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180710

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20180710

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20180731

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20181102

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190208

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20190208

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20190226

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20190320

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20190326

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20190426

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20190514

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20191224

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20200303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200407

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200414

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20200616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200616

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20200721

C30 Protocol of an oral hearing

Free format text: JAPANESE INTERMEDIATE CODE: C30

Effective date: 20200827

C30 Protocol of an oral hearing

Free format text: JAPANESE INTERMEDIATE CODE: C30

Effective date: 20200923

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200928

C302 Record of communication

Free format text: JAPANESE INTERMEDIATE CODE: C302

Effective date: 20200928

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20201027

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20201204

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20201209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201210

R150 Certificate of patent or registration of utility model

Ref document number: 6810991

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250